Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IDA for Onchocerciasis
PACTR201906665550709Not yet recruiting
- Sponsor
- Washington University in St. Louis
- Start
- Aug 2019
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of ivermectin, albendazole and diethylcarbamazine in onchocerciasis (3 arms), sponsored by Washington University in St. Louis. Planned start Aug 2019; status: not yet recruiting.
02
Drugs
ivermectinalbendazolediethylcarbamazine
03
Conditions
onchocerciasis
Beyond the preview
Go deeper on PACTR201906665550709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201906665550709.